Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Immunological Outcome in Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor: Assuit University Hospitals Insight

NCT03907670 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03907670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03907670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Immunological Outcome in Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor: Assuit University Hospitals Insight
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2019
Completion date
October 1, 2021
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic phase chronic myelogenous leukemia